OS

OraSure Technologies IncNASDAQ OSUR Stock Report

Last reporting period 30 Sep, 2024

Updated 20 Dec, 2024

Last price

Market cap $B

0.321

Micro

Exchange

XNAS - Nasdaq

OSUR Stock Analysis

OS

Uncovered

OraSure Technologies Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

60/100

Moderate score

Market cap $B

0.321

Dividend yield

Shares outstanding

73.245 B

OraSure Technologies, Inc. (OraSure) develops, manufactures, and distributes of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions. OraSure's segments consist of Diagnostics and Molecular Solutions. Diagnostics business segment primarily consists of the development, manufacture, marketing and sale of simple, easy to use diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products. The Diagnostics business includes tests for diseases including COVID-19, human immunodeficiency virus (HIV) and Hepatitis C that are performed on a rapid basis at the point of care, and tests for drugs of abuse that are processed in a laboratory. Molecular Solutions business products primarily consist of collection kits and services used by clinical laboratories, direct-to-consumer laboratories, researchers, pharmaceutical companies, and animal health service and product providers.

View Section: Eyestock Rating